title: Vonoprazan: MarKed Competition for PPIs?
authors.affiliation: Department of Physiology, DGSOM at UCLA, Los Angeles, CA, USA. dscott@ucla.edu.|VA GLAHS, 11301 Wilshire Blvd., Bldg. 113, Rm. 324, Los Angeles, CA, USA. dscott@ucla.edu.
authors.forename: David R
authors.initials: DR
authors.lastname: Scott
authors.affiliation: Department of Pediatrics, DGSOM at UCLA, Los Angeles, CA, USA.|VA GLAHS, 11301 Wilshire Blvd., Bldg. 113, Rm. 324, Los Angeles, CA, USA.
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Marcus
authors.affiliation: Department of Physiology, DGSOM at UCLA, Los Angeles, CA, USA.|Department of Medicine, DGSOM at UCLA, Los Angeles, CA, USA.|VA GLAHS, 11301 Wilshire Blvd., Bldg. 113, Rm. 324, Los Angeles, CA, USA.
authors.forename: George
authors.initials: G
authors.lastname: Sachs
mesh_terms: D006801:Humans; D054328:Proton Pump Inhibitors; D011758:Pyrroles; D013449:Sulfonamides
chemical_list: C552956:1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine; D054328:Proton Pump Inhibitors; D011758:Pyrroles; D013449:Sulfonamides